These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30844058)

  • 1. Inner sensors of endotoxin - implications for sepsis research and therapy.
    Skirecki T; Cavaillon JM
    FEMS Microbiol Rev; 2019 May; 43(3):239-256. PubMed ID: 30844058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic anti-endotoxin peptides inhibit cytoplasmic LPS-mediated responses.
    Pfalzgraff A; Heinbockel L; Su Q; Brandenburg K; Weindl G
    Biochem Pharmacol; 2017 Sep; 140():64-72. PubMed ID: 28539262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-canonical activation of inflammatory caspases by cytosolic LPS in innate immunity.
    Yang J; Zhao Y; Shao F
    Curr Opin Immunol; 2015 Feb; 32():78-83. PubMed ID: 25621708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses.
    Yi YS
    Immunology; 2017 Oct; 152(2):207-217. PubMed ID: 28695629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular Lipopolysaccharide Sensing as a Potential Therapeutic Target for Sepsis.
    Pfalzgraff A; Weindl G
    Trends Pharmacol Sci; 2019 Mar; 40(3):187-197. PubMed ID: 30691865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular and Extracellular Lipopolysaccharide Signaling in Sepsis: Avenues for Novel Therapeutic Strategies.
    Gabarin RS; Li M; Zimmel PA; Marshall JC; Li Y; Zhang H
    J Innate Immun; 2021; 13(6):323-332. PubMed ID: 34004605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide: an endotoxin or an exogenous hormone?
    Marshall JC
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S470-80. PubMed ID: 16237650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2.
    Wang Y; Shan X; Dai Y; Jiang L; Chen G; Zhang Y; Wang Z; Dong L; Wu J; Guo G; Liang G
    J Pharmacol Exp Ther; 2015 Jun; 353(3):539-50. PubMed ID: 25862641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A TLR4-independent critical role for CD14 in intracellular LPS sensing.
    Vasudevan SO; Russo AJ; Kumari P; Vanaja SK; Rathinam VA
    Cell Rep; 2022 May; 39(5):110755. PubMed ID: 35508125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis.
    Opal SM
    Int J Med Microbiol; 2007 Sep; 297(5):365-77. PubMed ID: 17452016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages.
    Chu LH; Indramohan M; Ratsimandresy RA; Gangopadhyay A; Morris EP; Monack DM; Dorfleutner A; Stehlik C
    Nat Commun; 2018 Mar; 9(1):996. PubMed ID: 29520027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of endotoxin response by synthetic TLR4 antagonists.
    Hawkins LD; Christ WJ; Rossignol DP
    Curr Top Med Chem; 2004; 4(11):1147-71. PubMed ID: 15279606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes.
    Man SM; Karki R; Sasai M; Place DE; Kesavardhana S; Temirov J; Frase S; Zhu Q; Malireddi RKS; Kuriakose T; Peters JL; Neale G; Brown SA; Yamamoto M; Kanneganti TD
    Cell; 2016 Oct; 167(2):382-396.e17. PubMed ID: 27693356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass Spectrometry-based Structural Analysis and Systems Immunoproteomics Strategies for Deciphering the Host Response to Endotoxin.
    Khan MM; Ernst O; Sun J; Fraser IDC; Ernst RK; Goodlett DR; Nita-Lazar A
    J Mol Biol; 2018 Aug; 430(17):2641-2660. PubMed ID: 29949751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncanonical inflammasome activation by intracellular LPS independent of TLR4.
    Kayagaki N; Wong MT; Stowe IB; Ramani SR; Gonzalez LC; Akashi-Takamura S; Miyake K; Zhang J; Lee WP; Muszyński A; Forsberg LS; Carlson RW; Dixit VM
    Science; 2013 Sep; 341(6151):1246-9. PubMed ID: 23887873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting bacterial endotoxin: two sides of a coin.
    Bosshart H; Heinzelmann M
    Ann N Y Acad Sci; 2007 Jan; 1096():1-17. PubMed ID: 17405910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of septic shock: implications for prevention and treatment.
    Calandra T
    J Chemother; 2001 Nov; 13 Spec No 1(1):173-80. PubMed ID: 11936363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response.
    Mollnes TE; Christiansen D; Brekke OL; Espevik T
    Adv Exp Med Biol; 2008; 632():253-63. PubMed ID: 19025127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP11 is a pattern recognition receptor for bacterial lipopolysaccharide in the cytosol of human macrophages.
    Rojas-Lopez M; Gil-Marqués ML; Kharbanda V; Zajac AS; Miller KA; Wood TE; Hachey AC; Egger KT; Goldberg MB
    Sci Immunol; 2023 Jul; 8(85):eabo4767. PubMed ID: 37478192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsis.
    Brandenburg K; Heinbockel L; Correa W; Lohner K
    Biochim Biophys Acta; 2016 May; 1858(5):971-9. PubMed ID: 26801369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.